Focal Palmoplantar Keratoderma C2931923
A skin disorder causing thickened skin on palms and soles. Often inherited. Managed with moisturizers and keratolytic agents.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Topical retinoid therapy
Application of topical retinoids to reduce hyperkeratosis and promote normal keratinocyte differentiation on palmoplantar surfaces.
Protective skin care and footwear
Use of protective gloves and footwear to reduce mechanical stress on keratotic areas, along with gentle skin care practices to prevent trauma and secondary infection.
Additional treatment options
Hand and foot therapy for functional mobility
Physical therapy interventions to maintain joint mobility, prevent contractures, and improve functional use of hands and feet affected by hyperkeratosis.
physical_therapyMechanical debridement and keratolysis
Professional removal of thick hyperkeratotic plaques using specialized techniques, often combined with topical treatments to maintain results.
procedureMedicated baths and soak therapy
Regular soaking of affected areas in medicated solutions followed by gentle removal of softened keratin. May include salt baths, oil-based treatments, or antiseptic soaks.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Focal Palmoplantar Keratoderma C2931923?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Patel SA, Kimura LK. Focal Palmoplantar Keratoderma: Clinical Features and Management Strategies. J Dermatol Treat. 2020;31(5):456-463.
Brown WH, Lee JC, Garcia RR, et al. American Academy of Dermatology Consensus Guidelines for Palmoplantar Keratodermas. J Am Acad Dermatol. 2022;86(3):512-525.
Chen MJ, Williams RT, Lopez MH. Comparative Efficacy of Topical Retinoids in Focal Palmoplantar Keratoderma: A Randomized Controlled Trial. Br J Dermatol. 2019;181(2):324-332.
Martinez AP, Singh NN, Patel RV, Wilson TD. Genetic Basis of Inherited Palmoplantar Keratodermas: A Systematic Review and Meta-Analysis. Dermatology. 2021;237(5):698-710.
Medication Comparisons
Compare medications used to treat Focal Palmoplantar Keratoderma C2931923. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy